Randomized Comparative Effectiveness Study of Complete vs Culprit-only Revascularization Strategies to Treat Multi-vessel Disease After Primary Percutaneous Coronary Intervention (PCI) for ST-segment Elevation Myocardial (STEMI) Infarction
Principal Investigator
David WoodOverview
Body Locations and Systems
Heart AttackDiagnosis and Therapy
Surgery and RehabilitationClinicalTrials.gov#
NCT01740479Status
RecruitingStudy Start/End
Jan 1, 2013 to Jan 1, 2019Locations
Diamond Health Care Centre, Vancouver General Hospital
Name/Title
Andrew StarovoytovPhone
604-875-5079Purpose of Study
To determine whether, on a background of optimal medical therapy, including ticagrelor, opening of all suitable narrowings or blockages found at the time of primary PCI for an acute heart attack is better than treating only the culprit lesion in patients with multi-vessel disease.
Eligibility
Visit ClinicalTrials.gov for more information.
Disclaimer
Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific clinical research trials only. If you have specific questions which require clinical expertise, please call your primary care physician.